Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

642
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
642
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
442

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeting the Tumor Extracellular Matrix: A New Frontier in Cancer Therapy.

Current cancer drug targets·2026
Same author

First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agents.

European journal of medicinal chemistry·2026
Same author

Carbonic anhydrase VIII as a regulator of intracellular calcium signaling: mechanistic insights and implications in human disease.

Molecular biology reports·2026
Same author

Conservation Planning and Reporting Implications of qPCR-based Multi-species eDNA Detection Under EU Environmental Regulations.

Environmental management·2026
Same author

Nano STING Agonist Inhibits Brain Metastases of Solid Tumors through Synergistic Chemotherapy, STING Activation, and Vascular Disruption.

ACS applied materials & interfaces·2026
Same author

When the host is not healthy: Rethinking tuberculosis drug targets in comorbid conditions.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Spinal cord injury induces acute microbiome shock and system-wide transcriptomic reprogramming.

iMeta·2026
Same journal

Chondroitin sulfate restores muscle mass via gut-muscle axis remodeling through sugar-bile acid metabolism reprogramming.

iMeta·2026
Same journal

A large-scale single-cell transcriptomic atlas indicates the immune panorama of influenza A infection.

iMeta·2026
Same journal

Accu16S/AccuITS: Accurate and broadly applicable amplicon sequencing for absolute microbiome quantification.

iMeta·2026
Same journal

Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells.

iMeta·2026
Same journal

Two stable gut microbiome guilds predict liver tumor class and treatment responses.

iMeta·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 10, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.4K

腸内微生物群と結核

Yanhua Liu1, Ling Yang1,2, Maryam Meskini3,4

  • 1Institute of Tuberculosis, Senior Department of Tuberculosis the Eighth Medical Center of PLA General Hospital Beijing China.

iMeta
|August 27, 2025
PubMed
まとめ
この要約は機械生成です。

腸内微生物群 (GM) は,結核 (TB) の進行と治療への反応に大きな影響を与えます. この双方向的な関係を理解することは,TBの新たな診断と治療戦略の開発の鍵です.

キーワード:
ミコバクテリア 結核人工知能腸内微生物群マイクロバイオームベースの診断オミックスの技術結核

さらに関連する動画

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K

関連する実験動画

Last Updated: Sep 10, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.4K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K

科学分野:

  • 微生物学
  • 免疫学
  • ゲノミクス

背景:

  • Mycobacterium tuberculosis (MTB) によって引き起こされる結核は,世界的な健康問題です.
  • 腸内微生物群 (GM) の変異は,TBの感受性,進行,薬剤反応とますます関連しています.

研究 の 目的:

  • 遺伝子組み換えと結核の複雑な関係に関する現在の研究を体系的に検討する.
  • 結核の診断,治療,予防におけるGMの可能性を調査する.

主な方法:

  • 既存の文献の体系的なレビューと分析
  • 双方向効果,薬物相互作用,免疫反応,技術的進歩 (マルチオミック,AI) に焦点を当てる.

主要な成果:

  • MTBの感染は,宿主の免疫と結核の進行に影響を与えるGMの不活性化を引き起こす.
  • GMの相互作用は,抗結核薬の有効性に影響する.
  • マルチオミクスとAIは GM-TBのダイナミクスを理解するのに不可欠です

結論:

  • 遺伝子組み換えは結核の病原化と治療に 重要な役割を果たしています
  • 将来の研究は,ワクチンの有効性,予防,診断,再発におけるGMの役割に焦点を当てなければならない.
  • 微生物群を基盤とした戦略は結核の制御に 有望な手段を提示しています